Department of Pathology and Pathophysiology, Medical School, Southeast University, Nanjing 210009, Jiangsu Province, China.
Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool L69 7BE, United Kingdom.
World J Gastroenterol. 2020 Dec 21;26(47):7513-7527. doi: 10.3748/wjg.v26.i47.7513.
Liver fibrosis progressing to liver cirrhosis and hepatic carcinoma is very common and causes more than one million deaths annually. Fibrosis develops from recurrent liver injury but the molecular mechanisms are not fully understood. Recently, the TLR4-MyD88 signaling pathway has been reported to contribute to fibrosis. Extracellular histones are ligands of TLR4 but their roles in liver fibrosis have not been investigated.
To investigate the roles and potential mechanisms of extracellular histones in liver fibrosis.
, LX2 human hepatic stellate cells (HSCs) were treated with histones in the presence or absence of non-anticoagulant heparin (NAHP) for neutralizing histones or TLR4-blocking antibody. The resultant cellular expression of collagen I was detected using western blotting and immunofluorescent staining. , the CCl-induced liver fibrosis model was generated in male 6-week-old ICR mice and in TLR4 or MyD88 knockout and parental mice. Circulating histones were detected and the effect of NAHP was evaluated.
Extracellular histones strongly stimulated LX2 cells to produce collagen I. Histone-enhanced collagen expression was significantly reduced by NAHP and TLR4-blocking antibody. In CCl-treated wild type mice, circulating histones were dramatically increased and maintained high levels during the duration of fibrosis-induction. Injection of NAHP not only reduced alanine aminotransferase and liver injury scores, but also significantly reduced fibrogenesis. Since the TLR4-blocking antibody reduced histone-enhanced collagen I production in HSC, the CCl model with TLR4 and MyD88 knockout mice was used to demonstrate the roles of the TLR4-MyD88 signaling pathway in CCl-induced liver fibrosis. The levels of liver fibrosis were indeed significantly reduced in knockout mice compared to wild type parental mice.
Extracellular histones potentially enhance fibrogenesis the TLR4-MyD88 signaling pathway and NAHP has therapeutic potential by detoxifying extracellular histones.
肝纤维化进展为肝硬化和肝癌非常常见,每年导致超过 100 万人死亡。纤维化是由反复的肝损伤引起的,但分子机制尚不完全清楚。最近,TLR4-MyD88 信号通路被报道有助于纤维化。细胞外组蛋白是 TLR4 的配体,但它们在肝纤维化中的作用尚未得到研究。
研究细胞外组蛋白在肝纤维化中的作用和潜在机制。
用组蛋白处理 LX2 人肝星状细胞(HSCs),并在存在或不存在非抗凝肝素(NAHP)的情况下用组蛋白处理,以中和组蛋白或 TLR4 阻断抗体。用 Western 印迹和免疫荧光染色检测胶原 I 的细胞表达。在雄性 6 周龄 ICR 小鼠和 TLR4 或 MyD88 敲除及其亲本小鼠中生成 CCl4 诱导的肝纤维化模型。检测循环组蛋白并评估 NAHP 的作用。
细胞外组蛋白强烈刺激 LX2 细胞产生胶原 I。NAHP 和 TLR4 阻断抗体显著降低了组蛋白增强的胶原表达。在 CCl4 处理的野生型小鼠中,循环组蛋白显著增加,并在纤维化诱导期间保持高水平。NAHP 注射不仅降低了丙氨酸氨基转移酶和肝损伤评分,而且还显著减少了纤维化。由于 TLR4 阻断抗体降低了 HSC 中组蛋白增强的胶原 I 产生,因此使用 TLR4 和 MyD88 敲除小鼠的 CCl4 模型来证明 TLR4-MyD88 信号通路在 CCl4 诱导的肝纤维化中的作用。与野生型亲本小鼠相比,敲除小鼠的肝纤维化水平确实显著降低。
细胞外组蛋白可能通过 TLR4-MyD88 信号通路增强纤维化,NAHP 通过解毒细胞外组蛋白具有治疗潜力。